FDA Inspection 1269613 — Kun Tuo Xincheng Pharmaceutical Research & Development
The FDA completed an inspection of Kun Tuo Xincheng Pharmaceutical Research & Development on April 24, 2025 in Chaoyang District. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 24, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chaoyang District (China)
Additional Details
Sponsor, Contract Research Organization